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and hypertension was found to have pancytopenia during
routine blood test. She was asymptomatic without any
bleeding symptoms. Complete blood count test results
were as follows: white cell count, 1.2  103/lL;
hemoglobin, 8.7 g/dL; and platelet count, 90  103/lL.
Her coagulation profile was normal and peripheral blood
morphology did not show any promyelocytes. Bone marrow
aspirate showed an increased number of promyelocytes
(Fig. 1A). Immunofluorescence staining with an
antipromyelocytic leukemia (anti-PML) antibody was posi-
tive and showed microparticulate distribution (Fig. 1C).
Fluorescence in situ hybridization testing for PML/retinoic
acid receptor alpha with dual-fusion and retinoic acid
receptor alpha break-apart probes was positive (Fig. 1D).
Based on these findings, diagnosis of acute PML (APL)
was made.Immunocytochemical labeling of the wild-type PML pro-
tein with the PG-M3 monoclonal antibody directed against
the amino terminal portion of the human PML gene product
produces a characteristic nuclear speckled pattern, which is
attributed to localization of the protein into discrete dots
(5–20/nucleus) termed as ‘‘PML nuclear bodies” (Fig. 1B)
[1]. In APL cells, the PML nuclear body architecture seems
to be disrupted and results in a microgranular pattern [2].
PML immunofluorescence staining is a rapid (90-minute
turnaround time) and reliable diagnostic test, usually done
by immunohistochemistry lab with a high sensitivity
(98.9%) and specificity (98.7%) in diagnosing APL and corre-
lates well with cytogenetic and molecular [3].
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Fig. 1 (A) Bone marrow aspirate showing increased number of promyelocytes. (B) Promyelocytic leukemia (PML) nuclear bodies.
(C) Immunofluorescence staining with an anti-PML antibody is positive and shows the microparticulate distribution. (D) Fluorescence
in situ hybridization testing for PML/retinoic acid receptor alpha with dual-fusion and retinoic acid receptor alpha break-apart
probes is positive.
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